Cargando…
Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease
BACKGROUND: This study aimed to reveal the prevalence of sodium-glucose co-transporter 2 (SGLT2) inhibitor treatment and its association with restenosis risk in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease. METHODS: We used the database of...
Autores principales: | Takahara, Mitsuyoshi, Soga, Yoshimitsu, Fujihara, Masahiko, Iida, Osamu, Kawasaki, Daizo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557214/ https://www.ncbi.nlm.nih.gov/pubmed/37798619 http://dx.doi.org/10.1186/s12933-023-01992-4 |
Ejemplares similares
-
Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022) -
Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019) -
Association of Smoking, Diabetes, and Dialysis with the Presence of Popliteal Lesions in Femoropopliteal Artery Disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023) -
Prognostic Value of the CHA
(2)
DS
(2)
-VASc Score after Endovascular Therapy for Femoral Popliteal Artery Lesions
por: Tomoi, Yusuke, et al.
Publicado: (2021) -
Inverse association of diabetes and dialysis with the severity of femoropopliteal lesions and chronic total occlusion: a cross-sectional study of 2056 cases
por: Takahara, Mitsuyoshi, et al.
Publicado: (2020)